Asosiy kontentga oʻtish
Maqola

Five-year outcomes of machine perfusion versus static cold storage in controlled donation after circulatory death kidney transplantation: a binational cohort study

Alexandros K. PapageorgiouUniversity Hospital ZurichFabian KaltUniversity Hospital ZurichFabian RösslerUniversity Hospital ZurichMarcel SchneiderUniversity Hospital ZurichJan Philipp JonasDepartment of Surgery and Transplantation, University Hospital Zurich and University of Zurich, Zurich, SwitzerlandKerstin HübelUniversity Hospital ZurichHarmacek DusanDepartment of Nephrology, University Hospital of Zurich, Zurich, SwitzerlandBenoît MesnardDepartment of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, FranceMara CvijeticUniversity Hospital ZurichJulien BranchereauDepartment of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, FranceSarvar AbdurakhmonovClinic for Surgery, Department of Internal Diseases, Faculty of Medicine, Karshi State University, Tashkent, UzbekistanSaydimurad IsmailovMatkarimov ZohidjonAklrom AkhmedovLukas FrickDepartment of Surgery and Transplantation, University Hospital Zurich and University of Zurich, Zurich, SwitzerlandFederico StorniUniversity Hospital of BernSeverin GloorUniversity Hospital of BernTimothy M. PawlikSwiss Transplant Cohort Study, University Hospital Basel, Basel, SwitzerlandDavid HoesslyTransplantation Center, Lausanne University Hospital (CHUV) and University of Lausanne, Basel, SwitzerlandMichael KollerUniversity of LausanneDéla GolshayanHUG - Hôpitaux Universitaires de Genéve, Lausanne, SwitzerlandM. PascualHUG - Hôpitaux Universitaires de Genéve, Lausanne, SwitzerlandFadi HaidarDivision of Nephrology and Transplantation Medicine, HOCH Cantonal Hospital St.Gallen, St. Gallen, Geneva, SwitzerlandChristian KuhnDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, St. Gallen, SwitzerlandNicolas Johannes MüllerDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Woolloongabba, QLD, AustraliaDavid W. JohnsonDepartment of General, Visceral and Transplant Surgery, University Hospital Muenster, University of Muenster, Münster, GermanyPhilipp HoubenDepartment of General, Visceral and Transplant Surgery, University Hospital Muenster, University of Muenster, Münster, GermanyAndreas PascherDepartment of General, Visceral and Transplant Surgery, University Hospital Muenster, University of Muenster, Münster, GermanyJosé OberholzerUniversity Hospital ZurichDilmurodjon EshmuminovDepartment of Surgery and Transplantation, University Hospital Zurich and University of Zurich, Zurich, Switzerland
2026en
ABI

Annotatsiya

While hypothermic machine perfusion reduces delayed graft function (DGF) after kidney transplantation, its long-term benefits in controlled donation after circulatory death (DCD) are uncertain in real-world practice. We evaluated whether perfusion improves 5-year death-censored graft survival compared to static cold storage in DCD by benchmarking outcomes against those of donation after brain death (DBD). After analyzing the United Network for Organ Sharing and Swiss Transplant Cohort Study registries, we created a 1:1 propensity-score-matched cohort to balance baseline characteristics. Among 44,552 DCD recipients (34,739 with perfusion; 9,813 with cold storage) and 180,898 DBD controls, the matched 5-year death-censored graft survival rate was 84.8% with perfusion versus 87.4% with cold storage (hazard ratio 1.08; P = 0.19). Perfusion significantly reduced the rate of DGF (35.7% vs. 44.9%; P < 0.001), while the rates of primary nonfunction and acute rejection were comparable. Both DCD groups achieved long-term outcomes equivalent to those of the DBD cohort. In conclusion, while machine perfusion confers a substantial early reduction in delayed graft function, static cold storage continues to deliver excellent 5-year graft survival. Both strategies yield excellent long-term outcomes comparable to those of DBD transplants. Crucially, these findings support expanding DCD programs to include older donors as a vital strategy to increase transplantation rates and reduce waitlist mortality. To optimize outcomes in these older DCD grafts, clinicians should aim to limit donor comorbidity, keep total ischemia time below 12–15 h, and utilize continuous rather than end-ischemic machine perfusion whenever logistically feasible.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar